Analysts Viewpoint Kymera Therapeutics Inc [KYMR] Shares Fall -1.21% on Thursday Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Insiders Updates KYMR’s latest rating updates from top analysts. Kymera Therapeutics Inc’s filing revealed that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million on
Analysts Viewpoint KYMR price target predicted to rise nearly 59 in 12 months The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or